Welcome to 2020!

30/01/2020

Dear Customers and Friends of Omixon, They say that parenthood changes you and whoever they are, it would seem they are right. In 2019, the extended Omixon family grew with two of our team having children: Miki having his fifth (yeah, seriously!) and myself having my first. I’m sure...

IT-Illuminating Talk with the Head of Software Development and Project Manager, Márton Pogány

28/11/2019

The following interview is part of the Omixon interview series that we are conducting with Key Opinion Leaders at Omixon. The next interviewee is the leader of Omixon’s R&D team, Márton Pogány, Head of Software Development and Project Manager, who gives us a glimpse of his project management techniques and the...

Let’s Get Social with Nóri!

31/10/2019

Sales person, communication expert and Head of Omixon’s Marketing Team – she is the always positive and smiley Nóri who answers questions this time. What is your profession? What did you study originally? I’m an economist and a marketing communications expert by degree, but I was always involved in...

NGS rEvolution – Minimal Residual Disease Detection <=> Maximal Relapse Prevention

29/10/2019

Development of techniques in molecular biology over the last couple of years has not influenced only rEvolution (revolution + evolution) in HLA typing but also in other segments of onco-diagnostics and transplant medicine. Evaluation and implementation of Next Generation Sequencing (NGS) technology in Minimal Residual Disease (MRD) detection and...

30 Years Peaceful Revolution, November 14-15, 2019

21/10/2019

We are happy to announce that Omixon is sponsoring the “30 Years Peaceful Revolution: From the Peptide to Treatment” Symposium at Universitätsklinikum Leipzig, Germany. Omixon’s Senior Field Application Scientist, Nina Lauterbach will give a 20-minute presentation on our products. Title of her talk: Analysis of High-resolution HLA Typing by...